MolMed Signs an Agreement With GlaxoSmithKline to Develop a Production Process for a Gene Therapy

MILAN, ITALY -- (Marketwire) -- 08/05/11 -- MolMed S.p.A. (MILAN: MLM) today announced that it has…

Continue Reading